Status:
COMPLETED
Incidence, Risk Factors, Severity and Prognosis of Necrotizing Enterocolitis in Turkey
Lead Sponsor:
Turkish Neonatal Society
Conditions:
Necrotizing Enterocolitis
Eligibility:
All Genders
1-3 years
Brief Summary
Necrotizing enterocolitis (NEC) is a gastrointestinal system disease characterized by inflammatory necrosis of the intestine mainly seen in premature infants, and continues to be an important cause of...
Detailed Description
Necrotizing enterocolitis (NEC) is a gastrointestinal system disease characterized by inflammatory necrosis of the intestine mainly seen in premature infants, and continues to be an important cause of...
Eligibility Criteria
Inclusion
- Newborns diagnosed with NEC in neonatal intensive care units
Exclusion
- Major congenital anomaly,
- congenital heart disease (except for atrial septal defect, ventricular septal defect, patent ductus arteriosus)
- Chromosomal anomaly
- Inherited metabolic disease
- Hypoxic ischemic encephalopathy
- Newborns who died within the first 48 hours of life
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04344639
Start Date
March 1 2019
End Date
April 1 2020
Last Update
April 14 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Tolga Hasan Çelik, MD
Ankara, Turkey (Türkiye), 06100
2
Tolga Hasan Çelik
Ankara, Turkey (Türkiye), 06100